ADAM ROTH: Open Payments
NPI 1457550428 · ANNAPOLIS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$15,441 in 26 payments from 4 companies in 2025. Trend: 2023 $19,517 · 2024 $33,613 · 2025 $15,441
Consulting: $7,460Speaker / faculty: $6,870Travel & lodging: $640Food & beverage: $471
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 21 | $15,341 |
| Otsuka America Pharmaceutical, Inc. | 3 | $71 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: LYBALVI, REXULTI, ARISTADA, CAPLYTA, TRINTELLIX.
Industry payments across MD — which companies pay providers there.
